Information  X 
Enter a valid email address
  Print          More announcements

Wednesday 11 February, 2009

Sanofi Aventis Groupe

Laurence Debroux Appointed Chief Strategic Offi...





PARIS, February 11 /PRNewswire/ --     Sanofi-aventis announced today that 
Laurence Debroux is appointed Senior
Vice-President, Chief Strategic Officer (CSO).



    In light of the implementation of the Group's development strategy, it
has been decided to create the position of Chief Strategic Officer at the
Executive Committee level.



    This position will cover all Group's business development and acquisition
activities as well as corporate planning, financial and economic evaluation
of internal and external projects, and strategic intelligence.



    The CSO will ensure that development projects are coherent with corporate
strategy and fulfill rigorous requirements for shareholder value creation.



    Laurence Debroux is appointed to this position and will report to Chris
Viehbacher, Chief Executive Officer of sanofi-aventis.



    Laurence was previously Senior Vice President, Chief Financial Officer.
She will keep this position and ensure an orderly transition pending the
imminent appointment of a new CFO.



    Laurence Debroux is a graduate of HEC (Ecole des Hautes Etudes
Commerciales). She began her career with Merrill Lynch in London, and then
worked in the Finance Department of the Elf Aquitaine Group from 1993 to
1996. She joined the Sanofi Group as Corporate Treasurer in 1996, and was
appointed Head of Financing/Treasury in 1997. From 2000 to 2004, she served
as Head of Strategic Planning, before becoming Deputy Chief Financial
Officer. As from March 2007 she was appointed Senior Vice President, Chief
Financial Officer and became a member of the Executive Committee in December
2008.



About sanofi-aventis

    Sanofi-aventis, a leading global pharmaceutical company, discovers,
develops and distributes therapeutic solutions to improve the lives of
everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York
(NYSE: SNY).



Sanofi-aventis http://www.sanofi-aventis.com

                                                                                                  

a d v e r t i s e m e n t